Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

2114 with DOI

2 strong · 17 moderate · 2 weak

Compilations

12026-05-10T21:03:34.518Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

40last ruled 2026-06-04

0 awaiting a ruling

Issued documents

62026-10-19T20:29:58.446Z

notice · info card · emergency

Searches

192 with no results

queries and counts on the build

Claims checked

5343 supported

43 supported · 10 not

Correspondence

0received

consent field ships in Phase 4

Edges

203

derivations recorded for this entity

Complete over 21 sources, 1 compilation, and 40 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/4-ho-dpt/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-19issueIssued notice
  4. 2026-09-07srcPsilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl]-and 3-[2-(cycloalkylamino)ethyl] indol-4-ols
  5. 2026-09-07srcOpioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects
  6. 2026-09-07srcDimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
  7. 2026-09-07srcInvestigation of the Structure-Activity Relationships of Psilocybin Analogues
  8. 2026-09-07srcStructure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice
  9. 2026-09-07srcThe Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors.
  10. 2026-09-07srcIdentification of 5-HT2A receptor signaling pathways associated with psychedelic potential
  11. 2026-09-07srcThe hydrochloride salt of 4-hydroxy-N,N-di-n-propyltryptamine (4-HO-DPT)
  12. 2026-09-07srcTolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
  13. 2026-09-07srcPsychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
  14. 2026-09-07srcPeakAL: Protons I Have Known and Loved, Too - Another Fifty Shades of Grey-Market Spectra. Supplementary Data
  15. 2026-09-07srcRecreational use, analysis and toxicity of tryptamines.
  16. 2026-09-07srcLower-Dose Psycholytic Therapy - A Neglected Approach
  17. 2026-09-07srcToxicology and Analysis of Psychoactive Tryptamines.
  18. 2026-09-07srcFurther Studies on Oxygenated Tryptamines with LSD-Like Activity Incorporating a Chiral Pyrrolidine Moiety
  19. 2026-09-07srcDipropyltryptamine in psychotherapy.
  20. 2026-09-07srcHallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
  21. 2026-09-07srcIn vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes.
  22. 2026-09-07srcLow doses of Dipropyltryptamine in psychotherapy.
  23. 2026-09-07src4-HO-DPT compound profile
  24. 2026-09-07srcTiHKAL: The Continuation
  25. 2026-09-04issueIssued emergency
  26. 2026-09-04issueIssued info_card
  27. 2026-09-04issueIssued notice
  28. 2026-06-04proposal38 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  29. 2026-06-04publicationPublication — backfill
  30. 2026-05-10revisionRevision 1
  31. 2026-05-10absenceSearched ClinicalTrials.gov for "4-HO-DPT dipropyltryptamine tryptamine psychedelic" — no results
  32. 2026-05-10absenceSearched PubMed for "4-HO-DPT 4-hydroxy-DPT dipropyltryptamine psychedelic" — no results
  33. 2026-05-10genGeneration — pipeline-v5 · with 5 morepipeline-v5
  34. 2026-05-10rungeneration run

The same entries, as forms: six forms.